Cambridge Biomedical has worked extensively in transferring bioanalytical technologies and successfully optimizing
and validating assays for use in commercial laboratories.
We work at all stages of assay development to ease transfer of your proprietary technology from your internal laboratory to a fully optimized and validated assay in a CAP/CLIA laboratory.
Our specific areas of expertise include: de novo assay development, assay technology transfer, optimization
and validation of novel or commercially available kits. We work with biological matrices from humans or
animals as well as both small and large molecules.
Our development capabilities are supported by a CLIA certified, CAP accredited laboratory capable of
processing 10 or 10,000 samples.
Methods and Technologies
We seamlessly adapt to your needs, bringing experience with most assay development methods and technologies including:
PCR, ELISA, MSD, RIA, HPLC, cell based assays, IHC, Luminex®, and flow cytometry.